The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Rosuvastatin postconditioning protects isolated hearts against ischemia–reperfusion injury: The role of radical oxygen species, PI 3K–Akt–GSK‐3β pathway, and mitochondrial permeability transition pore
Abstract
Summary: Aims: Glycogen synthase kinase‐3β (GSK‐3β) and mitochondrial permeability transition pore (mPTP) play an important role in myocardial ischemia–reperfusion injury. The aim of this study was to investigate whether postconditioning with rosuvastatin is able to reduce myocardial ischemia–reperfusion injury and clarify the potential mechanisms. Methods: Isolated rat hearts underwent 30 minutes of ischemia and 60 minutes of reperfusion in the presence or absence of rosuvastatin (1‐50 nmol/L). The activity of signaling pathway was determined by Western blot analysis, and Ca 2+‐induced mPTP opening was assessed by the use of a potentiometric method. Results: Rosuvastatin significantly reduced myocardial infarct size and improved cardiac function at 5 and 10 nmol/L. Protection disappeared at higher concentration and reverted to increased damage at 50 nmol/L. At 5 nmol/L, rosuvastatin increased the phosphorylation of protein kinase B (Akt) and GSK‐3β, concomitant with a higher Ca 2+ load required to open the mPTP. Rosuvastatin postconditioning also significantly increased superoxide dismutase activity and reduced malondialdehyde and radical oxygen species level. LY 294002, phosphatidylinositol‐3‐kinase (PI 3K) inhibitors, abolished these protective effects of rosuvastatin postconditioning. Conclusion: Rosuvastatin prevents myocardial ischemia–reperfusion injury by inducing phosphorylation of PI 3K–Akt and GSK‐3β, preventing oxidative stress and subsequent inhibition of mPTP opening.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The studies performed by Liu et al revealed that the reduction of circulating/intramuscular CoQ10 after statin treatment decreased the phosphorylation potential of adenosine diphosphate and the activity of mitochondrial complex I and IV, which contributes to mitochondrial dysfunction.31, 32, 33, 34”
From Effects of Coenzyme Q10 on Statin‐Induced Myopathy: An Updated Meta‐Analysis of Randomized Controlled Trials (2018) · cites this paper as [32]
Citations
Cites
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
Piot, C. A., Croisille, P., Staat, P., Thibault, H., Rioufol, G., Mewton, N., Belghiti, R. E., Cung, T. T., Bonnefoy‐Cudraz, E., Angoulvant, D., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071142 · Cited by 1,339
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Cung, T.-T., Morel, O., Cayla, G., Rioufol, G., Garcia-Dorado, D., Angoulvant, D., Bonnefoy-Cudraz, E., Guérin, P., Elbaz, M., Delarche, N., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1505489 · Cited by 713
Bernardi, P., & Lisa, F. D. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.023 · Cited by 503
Ong, S., Samangouei, P., Kalkhoran, S. B., & Hausenloy, D. J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.11.005 · Cited by 328
The mitochondrial permeability transition pore and ischemia-reperfusion injury
Baines, C. P. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0004-8 · Cited by 290
Karch, J., Kwong, J. Q., Burr, A. R., Sargent, M. A., Elrod, J. W., Peixoto, P. M., Martinez-Caballero, S., Osinska, H., Cheng, E. H.-Y., Robbins, J., et al. (2013) · eLife · doi:10.7554/elife.00772 · Cited by 290
Bell, R. M., & Yellon, D. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02816-4 · Cited by 261
Bejma, Ramires, J. A. F., & Ji (2000) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2000.00745.x · Cited by 203
Das, S., Wong, R. P., Rajapakse, N. C., Murphy, E., & Steenbergen, C. (2008) · Circulation Research · doi:10.1161/circresaha.108.178970 · Cited by 203
Effect of Cyclosporine on Left Ventricular Remodeling After Reperfused Myocardial Infarction
Mewton, N., Croisille, P., Gahide, G., Rioufol, G., Bonnefoy‐Cudraz, E., Sanchez, I., Cung, T. T., Sportouch, C., Angoulvant, D., Finet, G., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.052 · Cited by 198
Preconditioning delays Ca2+-induced mitochondrial permeability transition
Argaud, L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.003 · Cited by 180
Braunersreuther, V., & Jaquet, V. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868782 · Cited by 172
Napoli, P. D. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00306-6 · Cited by 155
Yao, L., Huang, X., Wang, Y., Cao, Y., Zhang, C.-C., & Zhu, Y. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00339.2009 · Cited by 115
Schriewer, J. M., Peek, C. B., Bass, J. T., & Schumacker, P. T. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000159 · Cited by 101
Effects of atorvastatin on the inflammation regulation and elimination of subdural hematoma in rats
Li, T., Wang, D., Tian, Y., Yu, H., Wang, Y., Quan, W., Cui, W., Zhou, L., Chen, J., Jiang, R., et al. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.04.009 · Cited by 100
Saotome, M., Katoh, H., Yaguchi, Y., Tanaka, T. L., Urushida, T., Satoh, H., & Hayashi, H. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00436.2008 · Cited by 86
Alano, C. C., Beutner, G., Dirksen, R. T., Gross, R. A., & Sheu, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00738.x · Cited by 72
Lim, W. Q. M., Messow, C., & Berry, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01691.x · Cited by 67
Li, H., Wang, Y., Wei, C., 白淑芝, Zhao, Y., Li, H., Wu, B., Wang, R., Wu, L., & Xu, C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0003-4 · Cited by 58
Bai, Y., Muqier, Murakami, H., Iwasa, M., Sumi, S., Yamada, Y., Ushikoshi, H., Aoyama, T., Nishigaki, K., Takemura, G., et al. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05550.x · Cited by 51
Bavry, A. A., Mood, G. R., Kumbhani, D. J., Borek, P., Askari, A. T., & Bhatt, D. L. (2007) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200707020-00005 · Cited by 47
Miura, T., Nishihara, M., & Miki, T. (2009) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r27fm · Cited by 46
Vilahur, G., Casaní, L., Peña, E., Durán, X., Juan‐Babot, O., & Badimón, L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.009 · Cited by 45
白, 玉. (2011) · Medical Entomology and Zoology · Cited by 39
Balance of Nitric Oxide and Reactive Oxygen Species in Myocardial Reperfusion Injury and Protection
Folino, A., Losano, G., & Rastaldo, R. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a50c45 · Cited by 32
Li, X., Xu, H., Chen, W., Chu, N., & Zhu, J. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.03.015 · Cited by 21
Wu, N., Li, W., Lv, Y., et al. (2014) · Die Pharmazie · doi:10.31083/ph.2014.4562 · Cited by 6
Cited by
Sorted by citations
Qu, H., Guo, M., Chai, H., Wang, W., Gao, Z., & Shi, D. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009835 · Cited by 178
Metadata
- Authors
- Liu, C., Yang, F., Cheng, S., Liu, Y., Wan, L., & Cong, H.
- Affiliations
- Tianjin Chest Hospital (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- Department of Thoracic Surgery Tianjin Chest Hospital Tianjin China
- Department of Cardiology Tianjin Medical University Tianjin Chest Hospital Tianjin China
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2016-12-13
- Volume
- 35
- Issue
- 1
- Pages
- 3-9
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- OpenAlex
- W2512501821
- Cited by
- 52
- References
- 28
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 1 · 2022: 5 · 2021: 9 · 2020: 7 · 2019: 6 · 2018: 9 · 2017: 7
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- rosuvastatin, myocardial ischemia-reperfusion injury, cardioprotection, postconditioning, GSK3β, PI3K/Akt signaling, mitochondrial permeability transition pore, oxidative stress, reactive oxygen species, superoxide dismutase, malondialdehyde, statins, myocardial infarct size, isolated rat heart
- MeSH terms
- Isolated Heart Preparation, Rosuvastatin Calcium, Glycogen Synthase Kinase 3 beta, Phosphoinositide-3 Kinase Inhibitors, Mitochondrial Permeability Transition Pore, Animals, Antioxidants, Disease Models, Animal, Dose-Response Relationship, Drug, Male, Mitochondria, Heart, Myocardial Infarction, Phosphorylation, Time Factors, Myocardial Reperfusion Injury, Ventricular Function, Left, Rats, Wistar, Reactive Oxygen Species, Oxidative Stress, Cytoprotection, Calcium Signaling, Myocytes, Cardiac, Mitochondrial Membrane Transport Proteins, Protein Kinase Inhibitors, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review